---
figid: PMC9278337__ytac201f2
pmcid: PMC9278337
image_filename: ytac201f2.jpg
figure_link: /pmc/articles/PMC9278337/figure/ytac201-F2/
number: Figure 2
figure_title: ''
caption: Coronary angiogram showing (A) diffuse disease in the right coronary artery
  with occlusion in the medial segment, (B) aortic coronary venous graft to the right
  coronary artery without relevant stenosis, (C) left coronary artery diffusely diseased
  with multiple stenoses and a high-degree left main stenosis, (D) sequential arterial
  bypass graft with the LIMA to the left anterior descending artery and right internal
  mammary internal artery connected to LIMA as a T-graft to left circumflex artery,
  (E) moderate plaque stenosis in the right common femoral artery and 70% degree stenosis
  in the right superficial femoral artery, and (F) diffuse atherosclerosis with moderate
  stenoses in both sided superficial arteries (tibial and fibular arteries not shown).
  LIMA, left internal mammary artery.
article_title: 'Clinical experience with dual pathway inhibition therapy: case series
  and mini review.'
citation: Tobias Geisler, et al. Eur Heart J Case Rep. 2022 Jul;6(7):ytac201.
year: '2022'

doi: 10.1093/ehjcr/ytac201
journal_title: 'European Heart Journal: Case Reports'
journal_nlm_ta: Eur Heart J Case Rep
publisher_name: Oxford University Press

keywords:
- dual pathway inhibition
- antithrombotic therapy
- rivaroxaban
- coronary artery disease
- peripheral artery disease
- case report

---
